John Orta - 12 Jun 2023 Form 4 Insider Report for Nextdoor Holdings, Inc. (KIND)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
14 Jun 2023, 16:29:29 UTC
Prior SEC filing
05 Jun 2023
Next SEC filing
06 Jul 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Sophia Contreras Schwartz, as Attorney-in-Fact for Reporting Person

Key filing fact

John Orta filed Form 4 for Nextdoor Holdings, Inc. (KIND) on 14 Jun 2023.

Key facts

  • This page summarizes John Orta's Form 4 filing for Nextdoor Holdings, Inc. (KIND).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 14 Jun 2023, 16:29.

Change

  • Previous filing in this sequence was filed on 05 Jun 2023.
  • Current net transaction value: -$7,250.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KIND transaction

Class A Common Stock

Sale

Transaction value
$7,250
Shares
-2,500
Change %
-0.44%
Price
$2.90
Shares after
561,423
Date
12 Jun 2023
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Sale of shares made pursuant to and in accordance with the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, under a plan adopted by the Reporting Person on March 2, 2023.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .